European Medicines Agency (EMA)

Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
European Regulator Willing To Use COVID-19 Boosters Targeting Omicron Variants
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
European Regulator Willing To Use COVID-19 Boosters Targeting Omicron Variants
Europe Holds Second COVID-19 Booster Dose For People Aged Under 80 Years
Deciphera Presents New Data Across Pipeline At ESMO Congress

European Medicines Agency (EMA) Recent News

Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod
After FDA Warning, EMA Reviewing J&J COVID-19 Jab For Rare Nerve Disorder: Reuters
Roche's Enspryng Wins European Approval For Spinal Cord, Optic Nerve Inflammation Disorder
Stealth BioTherapeutics Stock Surges On Elamipretide's European Orphan Drug Tag for Ultra-Rare Genetic Condition
Seelos's Amyotrophic Lateral Sclerosis Candidate, SLS-005 An Orphan Drug In Europe
Janssen's Multiple Sclerosis Treatment Scores European Approval
Merck's Keytruda/Chemo Combo Therapy Wins EU Backing For Esophageal Cancer
EMA Grants BioMarin's Request For Speedy Review of Hemophilia A Gene Therapy
Regeneron-Sanofi's Libtayo Scores CHMP's Positive Opinion For Two Advanced Cancer Settings
Myovant Sciences' Relugolix Combo Tablet For Uterine Fibroids Scores EMA Backing For Approval
Genmab - Janssen's Darzalex Wins Positive Opinion In Europe For Two New Indications
Larimar Shares Trade Higher On $95M Capital Raise, CTI-1601's Priority Medicines Tag In Europe
Albireo's Bylvay Wins Positive Opinion from EMA For Rare Pediatric Liver Disease
GlaxoSmithKline - Vir Biotech's Antibody COVID-19 Treatment Wins CHMP's Positive Scientific Opinion
Bluebird bio's Neurological Disorder Gene Therapy Wins CHMP Backing for Approval
European Union Announce Second Lawsuit Against AstraZeneca Over Delayed COVID-19 Vaccine Supply: Reuters
EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots
European Medical Agency (EMA) is reviewing reports of a rare nerve-degenerating disorder in people who received AstraZeneca P
Roche, AbbVie, Bristol-Myers Are Latest To Win European Medicines Agency's CHMP Positive Opinion
EMA Finds Potential Blood Clot Link With JNJ COVID-19 Shot, Adds Safety Warning
European Union Looks To Buy 1.8B Pfizer-BioNTech COVID-19 Vaccine Doses From 2022: Reuters
Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC
Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots
The European Medicines Agency (EMA), after an in-depth analysis, has concluded that unusual blood clots should be listed&nbs
AbbVie Files US, Europe Applications For Skyrizi In Psoriatic Arthritis